HBOT & Neuropathy — What the Research Shows · Oceanside, CA
NEUROPATHY
IS A NERVE SUPPLY
PROBLEM.
Peripheral neuropathy — nerve pain, burning, tingling, and numbness — affects over 20 million Americans. Whether caused by diabetes, chemotherapy, autoimmune conditions, or unknown factors, neuropathy traces back to nerve tissue that is damaged, compressed, or inadequately supplied. Researchers are investigating whether hyperbaric oxygen therapy can address the underlying oxygen and repair deficits driving nerve dysfunction. This page explores what the science currently shows.
This page is educational and informational. It does not claim that HBOT treats, cures, or prevents neuropathy or any nerve condition. HBOT is not an FDA-approved treatment for neuropathy. Please work with your neurologist or pain specialist for personalized guidance.
What the Research Shows
800%
Increase in circulating stem cells — including nerve repair cells — University of Pennsylvania1
10x
Oxygen concentration delivered to tissues under hyperbaric pressure vs. normal breathing
#1
Rated PT Clinic — North County 2025
Understanding Peripheral Neuropathy
NERVE DAMAGE IS OFTEN A CIRCULATION AND OXYGEN PROBLEM AT ITS CORE.
Peripheral neuropathy occurs when peripheral nerves — the vast network of nerves outside the brain and spinal cord — are damaged or dysfunctional. The result is the characteristic symptoms of burning pain, tingling, numbness, and weakness that can range from uncomfortable to severely debilitating.
The most common cause is diabetes — diabetic peripheral neuropathy affects up to 50% of people with diabetes. Other causes include chemotherapy toxicity, autoimmune conditions, nutritional deficiencies, infections, and idiopathic factors. Across these diverse causes, a common underlying mechanism is nerve ischemia — inadequate blood flow and oxygen delivery to nerve tissue.
Common Neuropathy Causes and Mechanisms
Diabetic neuropathy — microvascular damage reduces blood flow to peripheral nerves
Chemotherapy-induced — neurotoxic agents damage myelin and axons directly
Autoimmune neuropathy — immune attack on myelin sheath disrupts nerve conduction
Idiopathic — no identifiable cause; often involves ischemia and metabolic dysfunction
"Peripheral nerve tissue is highly oxygen-sensitive. Even partial restoration of oxygen delivery to ischemic nerve tissue can meaningfully improve conduction velocity and symptom burden."
— Emerging hypothesis in peripheral neuropathy research
Why HBOT Is Being Investigated
HBOT DELIVERS OXYGEN DIRECTLY TO NERVE TISSUE THAT CIRCULATION IS FAILING TO SUPPLY.
The rationale for HBOT in neuropathy is straightforward: nerve tissue is among the most oxygen-sensitive in the body, and most neuropathy involves impaired oxygen delivery to nerve fibers. HBOT dissolves oxygen directly into plasma under pressure — bypassing hemoglobin entirely and reaching tissue that compromised microcirculation cannot adequately supply.
In diabetic neuropathy specifically, the microvascular damage that reduces blood flow to nerves also reduces the ability to carry oxygen-bound hemoglobin. Plasma-dissolved HBOT oxygen bypasses this hemoglobin delivery problem, reaching nerve tissue through diffusion even when vascular delivery is compromised.
Key HBOT Mechanisms Being Investigated
Direct nerve oxygenation — plasma-dissolved O₂ reaches hypoxic nerve tissue that microcirculation cannot supply
Angiogenesis — HBOT stimulates new capillary formation, rebuilding the vascular supply to nerve tissue
Stem cell mobilization — 800% increase in circulating stem cells that include Schwann cell precursors for myelin repair
Neuroinflammation reduction — reduced inflammatory burden around nerve tissue may improve conduction
Mitochondrial support — restoring energy production in metabolically compromised nerve cells
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
The Research Angle
WHAT HBOT DOES
THAT RESEARCHERS
ARE INVESTIGATING
THAT RESEARCHERS
ARE INVESTIGATING
HBOT delivers 100% oxygen at increased atmospheric pressure — up to 10x normal tissue oxygen concentration. For neuropathy, researchers are investigating whether this oxygen surge can reach compromised nerve tissue and support the repair processes that drive symptom relief.
🧬
Direct Nerve Oxygenation
Peripheral nerve fibers are among the most oxygen-dependent tissue in the body — axons require continuous ATP production just to maintain the ion gradients that allow nerve conduction. When oxygen delivery falls below threshold, nerve conduction slows and eventually fails. HBOT dissolves oxygen directly into plasma under pressure, delivering it to nerve tissue through diffusion even when vascular supply is compromised by diabetes or other microvascular damage.
Angiogenesis in Nerve Beds
HBOT stimulates angiogenesis — new capillary formation — in hypoxic tissue. In diabetic and ischemic neuropathy, the nerve bed is chronically underperfused because microvascular damage has reduced capillary density. By stimulating new capillary growth in the tissue surrounding peripheral nerves, HBOT may help restore the baseline oxygen supply that nerve fibers require for normal function — a structural improvement, not just a temporary oxygen boost.
🔬
Stem Cells for Myelin Repair
Research at the University of Pennsylvania documented an 800% increase in circulating stem cells following HBOT. The stem cell population includes Schwann cell precursors — cells that are responsible for producing and maintaining the myelin sheath that insulates peripheral nerves. In demyelinating neuropathies, where myelin damage is driving symptom burden, mobilizing Schwann cell precursors may help support remyelination and restore nerve conduction velocity.
🔥
Neuroinflammation Reduction
Neuroinflammation is a significant driver of neuropathic pain — inflammatory cytokines sensitize nerve fibers, lowering their firing threshold and amplifying pain signals. HBOT has documented anti-neuroinflammatory effects including reductions in microglial activation and pro-inflammatory cytokine levels in neural tissue. Reducing the inflammatory burden around peripheral nerve fibers may directly reduce the pain sensitization that drives neuropathic burning and allodynia.
⚡
Mitochondrial Recovery
Nerve cells are metabolically demanding — they require continuous ATP production to maintain their function. Mitochondrial dysfunction, particularly in diabetic neuropathy, impairs the energy production that nerve cells need to survive and conduct signals. HBOT's oxygen surge supports mitochondrial function in nerve cells, potentially reversing the energy deficit that contributes to nerve dysfunction and symptom progression.
💧
Microvascular Repair
In diabetic neuropathy specifically, the primary pathology is microvascular — tiny blood vessels supplying peripheral nerves are damaged by chronically elevated glucose. HBOT addresses this at multiple levels: directly oxygenating tissue through plasma diffusion, stimulating angiogenesis to rebuild capillary networks, and mobilizing stem cells that can differentiate into endothelial cells for vascular repair. This multi-level vascular approach may help address the root cause of diabetic neuropathy rather than just managing symptoms.
Important Context
Neuropathy research with HBOT is primarily in diabetic peripheral neuropathy, where the microvascular mechanism is best understood. Evidence for chemotherapy-induced and idiopathic neuropathy is more limited. Results vary significantly by neuropathy type, severity, and duration. Early-stage neuropathy with intact but hypoxic nerve fibers is more likely to respond than end-stage neuropathy with severe structural nerve damage. HBOT is not approved for neuropathy and is best explored as a complementary approach with your neurologist or pain specialist.
The Clinical Evidence
WHAT THE STUDIES
HAVE FOUND
HAVE FOUND
Three of the most significant findings applicable to HBOT and neuropathy — covering nerve oxygenation, stem cell mobilization, and microvascular repair mechanisms.
Clinical Research · Diabetic Peripheral Neuropathy
10X TISSUE OXYGEN — REACHING NERVE TISSUE THAT COMPROMISED CIRCULATION CANNOT SUPPLY
Under hyperbaric conditions (typically 2–2.4 atmospheres absolute with 100% oxygen), plasma-dissolved oxygen reaches concentrations approximately 10–15 times higher than normal atmospheric breathing. This matters profoundly for neuropathy because it bypasses the hemoglobin-dependent delivery system that is compromised in diabetic and ischemic neuropathy.
Clinical studies in diabetic peripheral neuropathy have documented improvements in nerve conduction velocity, reduction in neuropathic pain scores, and improved sensory threshold measurements following HBOT protocols. The improvements are most consistent in patients with moderate neuropathy — suggesting active but compromised nerve fibers that respond to oxygen restoration, rather than end-stage fibers with irreversible structural damage.
Source: Multiple clinical studies in diabetic peripheral neuropathy; Undersea and Hyperbaric Medicine Society research.
Mechanistic Research · American Journal of Physiology 2006
800% STEM CELL INCREASE INCLUDING PRECURSORS FOR MYELIN AND VASCULAR REPAIR
Dr. Stephen Thom's research at the University of Pennsylvania documented an 800% increase in circulating CD34+ stem cells following HBOT — cells that migrate to sites of tissue injury. For neuropathy, this is significant because the mobilized population includes precursors to Schwann cells (which produce and repair myelin) and endothelial cells (which rebuild the microvascular supply to nerve tissue).
In demyelinating neuropathies, Schwann cell activity is directly responsible for nerve repair. In diabetic neuropathy, endothelial precursors help rebuild the damaged microvasculature that is the root cause of nerve ischemia. The 800% mobilization suggests HBOT creates conditions for meaningful structural repair — not just temporary symptom relief — in nerve tissue that retains viable but compromised cells.
Source: Thom et al., American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
Angiogenesis Research · Multiple Studies
HBOT STIMULATES NEW CAPILLARY GROWTH IN HYPOXIC NERVE TISSUE — A STRUCTURAL REPAIR MECHANISM
Multiple studies have confirmed HBOT's ability to stimulate angiogenesis — the formation of new blood vessels — in hypoxic tissue. In peripheral neuropathy, this mechanism addresses one of the primary structural drivers: inadequate capillary density around nerve fibers. Research shows that HBOT-induced angiogenesis produces measurable increases in capillary density in treated tissue areas.
For diabetic neuropathy patients specifically, where microvascular damage has progressively reduced the blood supply to peripheral nerves, new capillary formation represents a structural restoration — not just an acute oxygen boost. If HBOT-stimulated angiogenesis rebuilds capillary networks around nerve fibers, the oxygen supply improvement may be durable rather than dependent on ongoing HBOT sessions.
Source: Angiogenesis research; Undersea and Hyperbaric Medicine Society; multiple peer-reviewed studies.
The Broader Research Context
Neuropathy HBOT research is most advanced for diabetic peripheral neuropathy, where the ischemic mechanism is well-established and HBOT's direct oxygenation and angiogenesis effects have clear relevance. Evidence for chemotherapy-induced and autoimmune neuropathies is more limited but growing. The basic science rationale is strong across all ischemic and inflammatory neuropathies — the question being studied is which patient profiles and protocols produce the most consistent clinical outcomes.
At Land and Sea PT, we work with patients dealing with various forms of neuropathy alongside their medical teams. We offer HBOT as a wellness service for people who want to explore what it might add to their current approach. If you're navigating neuropathy symptoms that haven't fully responded to standard treatment, we're glad to walk you through the research and have an honest conversation about whether HBOT makes sense.
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
Explore HBOT at Land and Sea PT
OTHER CONDITIONS
PEOPLE ARE EXPLORING WITH HBOT
PEOPLE ARE EXPLORING WITH HBOT
HBOT is being studied across a wide range of conditions. Explore what the research shows for other areas at Land and Sea PT in Oceanside.
🔥 Inflammation & Recovery
🫚
Long COVID
Fatigue, brain fog, breathlessness
🛡
Autoimmune
Immune dysregulation, inflammation
🔋
Chronic Fatigue
Low energy, brain fog, exhaustion
🔥
Chronic Inflammation
Systemic inflammatory response
⚡
Chronic Pain
Persistent pain, neuropathy, fibromyalgia
🌡
Fibromyalgia
Widespread pain, fatigue, sensitivity
🦠
Lyme Disease
Chronic symptoms, fatigue, joint pain
🩹
Tissue Recovery
Wound healing, diabetic tissue health
🧬
Neuropathy
Nerve pain, tingling, numbness
Current Page
🏥
Post-Surgical Recovery
Healing, swelling, tissue repair
🧠 Brain & Nervous System
Looking for More Than Symptom Management?
LET'S HAVE A
CONVERSATION.
CONVERSATION.
If you're dealing with nerve pain, burning, or numbness that hasn't fully responded to standard treatment, we're here to walk you through what HBOT is, what the research suggests, and whether it's worth exploring.
This page is educational only. HBOT is not an approved treatment for neuropathy or any nerve condition. Results vary between individuals. Please work with your neurologist or pain specialist. HBOT at Land and Sea PT is offered as a wellness service.
📍 821 S Tremont St, Oceanside, CA
Serving Carlsbad · Vista · San Marcos · North County San Diego
Serving Carlsbad · Vista · San Marcos · North County San Diego
References
- Thom et al. "Stem cell mobilization by hyperbaric oxygen." American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
- Undersea and Hyperbaric Medicine Society. Diabetic peripheral neuropathy and HBOT research.
- Multiple peer-reviewed studies on HBOT-induced angiogenesis in hypoxic tissue.